AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Rebevap D 30mg/20mg Capsule SR

Prescription Icon
Prescription Required

Marketer

Ameha Healthcare

Salt Composition

Domperidone (30mg) + Rabeprazole (20mg)

Overview Rebevap D 30mg/20mg Capsule SR

Gastroesophageal reflux disease (GERD), or acid reflux, can be managed with Rebevap D 30mg/20mg sustained-release capsules, a dual-action formulation. This medication targets acid reflux symptoms like heartburn, abdominal pain, and discomfort by neutralizing stomach acid and facilitating gas expulsion. Follow your physician's prescribed dosage and duration; this is typically taken on an empty stomach. Treatment length depends on individual response and should continue as directed to prevent symptom recurrence and potential condition worsening. Always disclose all other medications to your healthcare provider, as interactions are possible. Common, usually transient, side effects include diarrhea, abdominal pain, dry mouth, headache, flatulence, and fatigue. Report any concerning side effects immediately. Drowsiness and dizziness are potential side effects; avoid driving or activities requiring alertness until the medication's effects are known. Alcohol consumption should be avoided due to potential increased drowsiness. Lifestyle adjustments, such as consuming cold milk and avoiding caffeine, spicy foods, and chocolate, may enhance treatment efficacy. Prior to commencing treatment, inform your doctor about any existing liver or kidney conditions, pregnancy, pregnancy plans, or breastfeeding.

Uses of Rebevap D 30mg/20mg Capsule SR

Managing gastroesophageal reflux and peptic ulcers.

Major Benefits of Rebevap D 30mg/20mg Capsule SR:

Administer this medication precisely as prescribed by your physician, adhering to the recommended dosage and treatment period. Ingest the capsule whole; avoid chewing, crushing, or fracturing it. Consume Rebevap D 30mg/20mg Sustained-Release Capsules on an empty stomach.

Common Side effects of Rebevap D 30mg/20mg Capsule SR:

  • Cough
  • Headache
  • Diarrhea
  • Dizziness
  • Inflammation of the nose
  • Abdominal pain
  • Vomiting
  • Weakness
  • Nasal congestion (stuffy nose)
  • Insomnia (difficulty in sleeping)
  • Fundic gland polyps
  • Nausea
  • Constipation
  • Flatulence
  • Back pain
  • Pharyngitis

How to use Rebevap D 30mg/20mg Capsule SR:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Consume Rebevap D 30mg/20mg SR Capsules on an empty stomach.

How Rebevap D 30mg/20mg Capsule SR works:

Rebevap D 30mg/20mg sustained-release capsules contain Domperidone and Rabeprazole. Domperidone, a gastrointestinal motility stimulant, enhances upper digestive tract movement, facilitating faster food transit. Rabeprazole, a proton pump inhibitor (PPI), decreases stomach acid production, providing relief from acid indigestion and heartburn symptoms.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when using Rebevap D 30mg/20mg Capsule SR with alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Rebevap D 30mg/20mg capsules may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a developing fetus. Prescribing decisions will consider the potential benefits against these risks. Physician consultation is advised.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Rebevap D 30mg/20mg capsules are likely unsafe for breastfeeding mothers. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.

DrivingDrivingUNSAFE

Taking Rebevap D 30mg/20mg sustained-release capsules might reduce attentiveness, impair vision, or cause drowsiness and dizziness. Refrain from driving if these effects are experienced.

KidneyKidneyCAUTION

Patients with impaired kidney function should use Rebevap D 30mg/20mg sustained-release capsules cautiously. A modified dosage of Rebevap D 30mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Rebevap D 30mg/20mg sustained-release capsules cautiously, potentially requiring dosage modification. Physician consultation is advised. Rebevap D 30mg/20mg sustained-release capsules are contraindicated in individuals with moderate to severe hepatic dysfunction.

What if you forget to take Rebevap D 30mg/20mg Capsule SR :

Should you forget a Rebevap D 30mg/20mg SR Capsule dose, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual regimen. Avoid taking a double dose.

Facts to Know About Rebevap D 30mg/20mg Capsule SR

LabelValue
Potential for Dependence None.
Type of Medication Gastrointestinal system

FAQs on Rebevap D 30mg/20mg Capsule SR

Rebevap D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation addresses acidity, heartburn, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It also provides relief from gastric and duodenal ulcers. The domperidone component facilitates improved gut motility, thereby easing food passage through the stomach and mitigating vomiting.
Patients exhibiting hypersensitivity to rabeprazole, domperidone, or any inactive components of Rebevap D 30mg/20mg SR Capsules should avoid its use. Individuals with pre-existing kidney or liver conditions require careful monitoring when considering this medication.
Indeed, taking Rebevap D 30mg/20mg SR capsules may lead to xerostomia. This side effect is attributed to the Domperidone component. To alleviate dry mouth, increase your fluid intake. Keep a water source readily available overnight. Reduce alcohol consumption and refrain from smoking. For dry mouth relief, consider alcohol-free mouthwash to minimize the potential for dental caries.
Indeed, diarrhea is a possible side effect of Rebevap D 30mg/20mg SR Capsules. Should diarrhea occur, increased fluid intake is recommended. Consuming greasy or fried foods while taking this medication should be avoided. Persistent diarrhea or signs of dehydration, such as reduced urination accompanied by dark, concentrated urine, warrant immediate medical consultation.
Maintain this medication within its original, securely sealed container. Follow the storage guidelines specified on the packaging or label. Discard any remaining medication. Prevent accidental ingestion by children, pets, and others.
Rebevap D 30mg/20mg sustained-release capsules are generally well-tolerated. Nevertheless, some individuals may experience typical adverse effects such as abdominal discomfort, diarrhea, flatulence, dry mouth, vertigo, or headache. Less frequent or infrequent side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Rebevap D 30mg/20mg sustained-release capsules is before the initial meal or while fasting.
Taking Rebevap D 30mg/20mg sustained-release capsules may elevate the likelihood of experiencing an abnormal heart rhythm, a potentially serious complication. While this adverse event is infrequent, the risk might be marginally greater for individuals over 60.
Rebevap D 30mg/20mg sustained-release capsules contain domperidone and rabeprazole. This dual-action formulation addresses symptoms of acidity, heartburn, and gastroesophageal reflux disease (GERD), a condition characterized by stomach acid reflux into the esophagus. It's also indicated for treating gastric and duodenal ulcers. Domperidone's role is to manage nausea and vomiting by stimulating gastrointestinal motility, facilitating efficient food passage through the stomach.
Individuals exhibiting hypersensitivity to rabeprazole, domperidone, or any excipient in Rebevap D 30mg/20mg SR Capsules should avoid its use. Patients with pre-existing hepatic or renal impairment require careful monitoring when considering this medication.
Indeed, taking Rebevap D 30mg/20mg SR capsules may lead to xerostomia (dry mouth), a side effect attributed to the domperidone component. To alleviate this, increase your fluid intake. Keeping water readily available, especially overnight, is advisable. Reducing alcohol consumption and abstaining from smoking are also recommended. Should dry mouth persist, consider using alcohol-free mouthwash to minimize the potential for dental caries.
Indeed, diarrhea is a potential side effect of Rebevap D 30mg/20mg SR Capsules. Should diarrhea occur, increased fluid intake is recommended. Consuming greasy or deep-fried foods should be avoided while taking this medication. Consult your physician if diarrhea continues or if you observe dehydration symptoms such as reduced urination accompanied by dark, strong-smelling urine.
Rebevap D 30mg/20mg SR capsules are generally well-tolerated. Nevertheless, some individuals may experience common adverse reactions including diarrhea, abdominal pain, flatulence, dry mouth, vertigo, and headache. Less frequent or rare side effects are also possible. Report any ongoing issues to your physician during treatment.
Optimal administration of Rebevap D 30mg/20mg sustained-release capsules is before breakfast or while fasting.
Taking Rebevap D 30mg/20mg Sustained-Release Capsules may raise the likelihood of an irregular heart rhythm (severe arrhythmias). While this is a serious potential adverse reaction, the probability of occurrence is quite small. Individuals over 60 years old might face a marginally elevated risk.
Retain this medication within its original, sealed container or packaging. Follow the storage guidelines provided on the packaging or label. Discard any remaining medication. Ensure it remains inaccessible to children, pets, and others.
Rebevap D 30mg/20mg Capsu...
98
MRP 119
17% off